• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极早产儿呼吸窘迫综合征和支气管肺发育不良的早期呼吸管理:病例对照研究。

Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study.

机构信息

Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

PLoS One. 2007 Feb 7;2(2):e192. doi: 10.1371/journal.pone.0000192.

DOI:10.1371/journal.pone.0000192
PMID:17285145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1781338/
Abstract

BACKGROUND

In the period immediately after birth, preterm infants are highly susceptible to lung injury. Early nasal continuous positive airway pressure (ENCPAP) is an attempt to avoid intubation and may minimize lung injury. In contrast, ENCPAP can fail, and at that time surfactant rescue can be less effective.

OBJECTIVE

To compare the pulmonary clinical course and outcome of very preterm infants (gestational age 25-32 weeks) with respiratory distress syndrome (RDS) who started with ENCPAP and failed (ECF group), with a control group of infants matched for gestational age, who were directly intubated in the delivery room (DRI group). Primary outcome consisted of death during admission or bronchopulmonary dysplasia (BPD).

RESULTS

25 infants were included in the ECF group and 50 control infants matched for gestational age were included in the DRI group. Mean gestational age and birth weight in the ECF group were 29.7 weeks and 1,393 g and in the DRI group 29.1 weeks and 1,261 g (p = NS). The incidence of BPD was significantly lower in the ECF group than in the DRI group (4% vs. 35%; P<0.004; OR 12.6 (95% CI 1.6-101)). Neonatal mortality was similar in both groups (4%). The incidence of neonatal morbidities such as severe cerebral injury, patent ductus arteriosus, necrotizing enterocolitis and retinopathy of prematurity, was not significantly different between the two groups.

CONCLUSION

A trial of ENCPAP at birth may reduce the incidence of BPD and does not seem to be detrimental in very preterm infants. Randomized controlled trials are needed to test whether early respiratory management of preterm infants with RDS plays an important role in the development of BPD.

摘要

背景

在出生后的早期阶段,早产儿极易受到肺损伤的影响。早期鼻持续气道正压通气(ENCPAP)是一种避免插管的尝试,可最大程度地减少肺损伤。相比之下,ENCPAP 可能会失败,此时表面活性物质抢救可能效果较差。

目的

比较患有呼吸窘迫综合征(RDS)的极早产儿(胎龄 25-32 周)接受 ENCPAP 治疗但失败(ECF 组)与直接在产房行气管插管的对照组(DRI 组)的肺部临床病程和结局。主要结局包括住院期间死亡或支气管肺发育不良(BPD)。

结果

25 例 ECF 组患儿和 50 例胎龄匹配的 DRI 组对照组患儿纳入研究。ECF 组患儿的平均胎龄和出生体重分别为 29.7 周和 1393g,DRI 组分别为 29.1 周和 1261g(p=NS)。ECF 组患儿的 BPD 发生率明显低于 DRI 组(4%比 35%;P<0.004;OR 12.6(95%CI 1.6-101))。两组患儿的新生儿死亡率相似(4%)。两组患儿严重脑损伤、动脉导管未闭、坏死性小肠结肠炎和早产儿视网膜病变等新生儿并发症的发生率无显著差异。

结论

在出生时尝试 ENCPAP 可能会降低 BPD 的发生率,并且似乎对极早产儿没有不利影响。需要开展随机对照试验,以检验 RDS 早产儿的早期呼吸管理是否对 BPD 的发生发展有重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d74/1781338/168dc70a6793/pone.0000192.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d74/1781338/91e5ca867ea6/pone.0000192.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d74/1781338/168dc70a6793/pone.0000192.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d74/1781338/91e5ca867ea6/pone.0000192.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d74/1781338/168dc70a6793/pone.0000192.g002.jpg

相似文献

1
Early respiratory management of respiratory distress syndrome in very preterm infants and bronchopulmonary dysplasia: a case-control study.极早产儿呼吸窘迫综合征和支气管肺发育不良的早期呼吸管理:病例对照研究。
PLoS One. 2007 Feb 7;2(2):e192. doi: 10.1371/journal.pone.0000192.
2
Is it safer to intubate premature infants in the delivery room?在产房为早产儿插管更安全吗?
Pediatrics. 2005 Jun;115(6):1660-5. doi: 10.1542/peds.2004-2493.
3
Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.经鼻持续气道正压通气与肺表面活性物质联合鼻塞式气道正压通气治疗早产儿呼吸窘迫综合征的临床疗效比较 目的:探讨经鼻持续气道正压通气(NCPAP)与肺表面活性物质(PS)联合鼻塞式气道正压通气(CPAP)治疗早产儿呼吸窘迫综合征(NRDS)的临床疗效。方法:选择 2019 年 1 月至 2020 年 12 月在我院接受治疗的 86 例 NRDS 早产儿作为研究对象,按照随机数字表法分为观察组和对照组,每组 43 例。观察组给予 NCPAP 联合 PS 治疗,对照组给予 CPAP 联合 PS 治疗。比较两组患儿的临床疗效、血气指标、机械通气时间、住院时间及不良反应发生情况。结果:观察组患儿的总有效率为 95.35%,明显高于对照组的 76.74%(P<0.05)。治疗后,观察组患儿的 PaO2、SaO2 水平明显高于对照组,PaCO2 水平明显低于对照组(P<0.05)。观察组患儿的机械通气时间和住院时间明显短于对照组(P<0.05)。观察组患儿的不良反应总发生率为 4.65%,明显低于对照组的 18.60%(P<0.05)。结论:NCPAP 联合 PS 治疗 NRDS 早产儿的临床疗效优于 CPAP 联合 PS 治疗,能有效改善血气指标,缩短机械通气时间和住院时间,降低不良反应发生率。
BMC Pulm Med. 2022 Dec 5;22(1):462. doi: 10.1186/s12890-022-02270-x.
4
Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.微创表面活性剂治疗与假治疗对呼吸窘迫综合征早产儿的死亡或支气管肺发育不良的影响:OPTIMIST 随机临床试验。
JAMA. 2021 Dec 28;326(24):2478-2487. doi: 10.1001/jama.2021.21892.
5
Sustained lung inflation at birth via short binasal prong in very low birth weight preterm infants: A retrospective study.经鼻持续正压通气在极低出生体重早产儿中的应用:一项回顾性研究。
Pediatr Pulmonol. 2018 Oct;53(10):1407-1413. doi: 10.1002/ppul.24130. Epub 2018 Jul 12.
6
Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial).“IN-REC-SUR-E”与 LISA 在呼吸窘迫综合征早产儿中的比较:一项随机对照试验(IN-REC-LISA 试验)。
Trials. 2024 Jul 2;25(1):433. doi: 10.1186/s13063-024-08240-4.
7
Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.经鼻给予肺表面活性物质与气管内给予肺表面活性物质后行小潮气量通气治疗中国呼吸窘迫综合征早产儿的随机对照试验研究方案
Trials. 2020 Jun 11;21(1):516. doi: 10.1186/s13063-020-04390-3.
8
Impact of implementation of 2019 European respiratory distress syndrome guidelines on bronchopulmonary dysplasia in very preterm infants.2019 年欧洲呼吸窘迫综合征指南实施对极早产儿支气管肺发育不良的影响。
Ital J Pediatr. 2024 Sep 16;50(1):178. doi: 10.1186/s13052-024-01752-4.
9
The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.表面活性剂给药技术(肺内滴注法与气管插管-肺表面活性物质给药法)对早产儿呼吸窘迫综合征治疗结局的影响。
Dev Period Med. 2019;23(3):163-171. doi: 10.34763/devperiodmed.20192303.163171.
10
Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.经表面活性物质治疗的早产儿呼吸窘迫综合征(胎龄<30 周)行鼻间歇正压通气:一项随机对照试验。
J Perinatol. 2012 May;32(5):336-43. doi: 10.1038/jp.2012.1. Epub 2012 Feb 2.

引用本文的文献

1
Cardiorespiratory Monitoring during Neonatal Resuscitation for Direct Feedback and Audit.新生儿复苏期间的心肺监测用于直接反馈和审计。
Front Pediatr. 2016 Apr 18;4:38. doi: 10.3389/fped.2016.00038. eCollection 2016.
2
Ventilator-induced lung injury in preterm infants.早产儿呼吸机所致肺损伤
Rev Bras Ter Intensiva. 2013 Oct-Dec;25(4):319-26. doi: 10.5935/0103-507X.20130054.
3
Leptin promotes fetal lung maturity and upregulates SP-A expression in pulmonary alveoli type-II epithelial cells involving TTF-1 activation.

本文引用的文献

1
The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: neonatal resuscitation.国际复苏联合委员会(ILCOR)关于儿科和新生儿患者的科学共识及治疗建议:新生儿复苏
Pediatrics. 2006 May;117(5):e978-88. doi: 10.1542/peds.2006-0350. Epub 2006 Apr 17.
2
Variables associated with the early failure of nasal CPAP in very low birth weight infants.与极低出生体重儿鼻持续气道正压通气早期失败相关的变量。
J Pediatr. 2005 Sep;147(3):341-7. doi: 10.1016/j.jpeds.2005.04.062.
3
Transition/adaptation in the delivery room and less RDS: "Don't just do something, stand there!".
瘦素促进胎肺成熟,并通过激活 TTF-1 上调肺泡 II 型上皮细胞表面活性蛋白 A 的表达。
PLoS One. 2013 Jul 22;8(7):e69297. doi: 10.1371/journal.pone.0069297. Print 2013.
4
Clinical practice : noninvasive respiratory support in newborns.临床实践:新生儿的无创呼吸支持。
Eur J Pediatr. 2010 Jul;169(7):777-82. doi: 10.1007/s00431-010-1159-x. Epub 2010 Feb 24.
5
What's new in surfactant? A clinical view on recent developments in neonatology and paediatrics.表面活性剂领域有哪些新进展?新生儿学和儿科学近期发展的临床视角。
Eur J Pediatr. 2007 Sep;166(9):889-99. doi: 10.1007/s00431-007-0501-4. Epub 2007 May 22.
产房内的过渡/适应与减少呼吸窘迫综合征:“不要只是瞎忙,站在那儿!”
J Pediatr. 2005 Sep;147(3):284-6. doi: 10.1016/j.jpeds.2005.05.003.
4
Is it safer to intubate premature infants in the delivery room?在产房为早产儿插管更安全吗?
Pediatrics. 2005 Jun;115(6):1660-5. doi: 10.1542/peds.2004-2493.
5
Neonatal resuscitation 3: manometer use in a model of face mask ventilation.新生儿复苏3:面罩通气模型中压力计的使用
Arch Dis Child Fetal Neonatal Ed. 2005 Sep;90(5):F397-400. doi: 10.1136/adc.2004.064709. Epub 2005 May 4.
6
Comparison of three manual ventilation devices using an intubated mannequin.使用插管人体模型对三种手动通气设备进行比较。
Arch Dis Child Fetal Neonatal Ed. 2004 Nov;89(6):F490-3. doi: 10.1136/adc.2003.047712.
7
Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants?极低出生体重儿使用鼻持续气道正压通气的经验会随着时间推移而改善吗?
Pediatrics. 2004 Sep;114(3):697-702. doi: 10.1542/peds.2003-0572-L.
8
Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial.极低出生体重儿产房持续气道正压通气/呼气末正压通气:一项可行性试验
Pediatrics. 2004 Sep;114(3):651-7. doi: 10.1542/peds.2004-0394.
9
Incomplete protection by prophylactic surfactant against the adverse effects of large lung inflations at birth in immature lambs.预防性表面活性剂对未成熟羔羊出生时大肺膨胀不良反应的保护作用不完全。
Intensive Care Med. 2004 Jul;30(7):1446-53. doi: 10.1007/s00134-004-2227-3. Epub 2004 Mar 25.
10
Can mechanical ventilation strategies reduce chronic lung disease?机械通气策略能否降低慢性肺病的发生率?
Semin Neonatol. 2003 Dec;8(6):441-8. doi: 10.1016/S1084-2756(03)00124-6.